Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Leukemia, Lymphocytic, Chronic, B-Cell 21Congenital Abnormalities 21Leukemia 20Lymphoma, Follicular 19Lymphoma, B-Cell, Marginal Zone 19Breast Neoplasms 19Multiple Myeloma 17Lymphoma, Mantle-Cell 17Myelodysplastic Syndromes 15Lymphoma, Non-Hodgkin 15Lymphoma, Large B-Cell, Diffuse 15Myeloproliferative Disorders 13Lymphoma, Large-Cell, Immunoblastic 13Lymphoma 13Burkitt Lymphoma 13Blast Crisis 13Lymphoma, T-Cell, Cutaneous 12Leukemia, Myelomonocytic, Chronic 12Leukemia, Myeloid, Accelerated Phase 12Sezary Syndrome 11Mycosis Fungoides 11Leukemia, Myeloid, Chronic-Phase 11Neoplasms, Plasma Cell 10Hodgkin Disease 10Waldenstrom Macroglobulinemia 9Primary Myelofibrosis 9Pdgfra-Associated Chronic Eosinophilic Leukemia 8Leukemia, Neutrophilic, Chronic 8

Interventions

Cyclophosphamide 23Paclitaxel 19Epirubicin 14Doxorubicin 13Carboplatin 13Trastuzumab 12Docetaxel 10Taxes 9Albumin-Bound Paclitaxel 7pembrolizumab 5Radiotherapy 5Fluorouracil 5Filgrastim 5Bevacizumab 5130-nm albumin-bound paclitaxel 5pertuzumab 4Neoadjuvant Therapy 4Cisplatin 4eribulin 3Thiotepa 3Tamoxifen 3Panitumumab 3Melphalan 3Magnetic Resonance Spectroscopy 3Flow Cytometry 3Capecitabine 3Biopsy 3sargramostim 2Specimen Handling 2Peripheral Blood Stem Cell Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Inflammatory Breast Neoplasms × Flow Cytometry × Clear all
NCT00513695 2019-08-07

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

University of Washington

Phase 2 Completed
68 enrolled 10 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00986609 2018-07-23

MUC1 Vaccine for Triple-negative Breast Cancer

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
29 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00004261 2018-02-22

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

University Health Network, Toronto

Phase 1 Terminated
BreastGenitourinaryGynecologicHead & NeckSarcoma

Breast Carcinoma In Situ, Breast Neoplasms, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡